Display options
Cite
Godinho MV, Lopes FPPL, Costa FM. Whole-body magnetic resonance imaging for the assessment of metastatic breast cancer. Cancer Manag Res. 2018;10:6743-6756doi: 10.2147/CMAR.S167924.
Godinho, M. V., Lopes, F. P. P. L., & Costa, F. M. (2018). Whole-body magnetic resonance imaging for the assessment of metastatic breast cancer. Cancer management and research, 106743-6756. https://doi.org/10.2147/CMAR.S167924
Godinho, Marcos Vieira, et al. "Whole-body magnetic resonance imaging for the assessment of metastatic breast cancer." Cancer management and research vol. 10 (2018): 6743-6756. doi: https://doi.org/10.2147/CMAR.S167924
Godinho MV, Lopes FPPL, Costa FM. Whole-body magnetic resonance imaging for the assessment of metastatic breast cancer. Cancer Manag Res. 2018 Dec 06;10:6743-6756. doi: 10.2147/CMAR.S167924. eCollection 2018. PMID: 30584368; PMCID: PMC6289208.
Copy Download .nbib Format: NLM
Share it on

Cancer Manag Res. 2018 Dec 06;10:6743-6756. doi: 10.2147/CMAR.S167924. eCollection 2018.

Whole-body magnetic resonance imaging for the assessment of metastatic breast cancer.

Cancer management and research

Marcos Vieira Godinho, Flavia Paiva Proença Lobo Lopes, Flavia Martins Costa

Affiliations

  1. Clinic of Imaging Diagnosis (CDPI), Rio de Janeiro, RJ, Brazil, [email protected].
  2. National Institute of Cancer (INCa), Rio de Janeiro, RJ, Brazil, [email protected].
  3. Radiology Department, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil.

PMID: 30584368 PMCID: PMC6289208 DOI: 10.2147/CMAR.S167924

Abstract

Breast cancer is the most common type of tumor in women and an important cause of mortality in the female population. The early and precise diagnosis, staging, and treatment of this neoplasia are essential for public health purposes. Technological development, for example, of whole-body magnetic resonance imaging, made possible the adoption of new imaging modalities for a better approach for these patients. This imaging modality is helpful to staging, to therapy response assessment, and to the study of therapeutic changes in bone marrow, because it gives, at the same time, anatomical information using T1- and T2-weighted images, with high spatial resolution and tissue contrast, as well as functional sequences (diffusion-weighted images), which make possible the detection of hypercellular viable tumors.

Keywords: chemotherapy; diffusion; heterogeneity; hypercellularity; necrosis; staging

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

References

  1. J Pharmacol Exp Ther. 2002 Sep;302(3):1055-61 - PubMed
  2. AJR Am J Roentgenol. 2004 May;182(5):1207-13 - PubMed
  3. Ann Intern Med. 2006 May 16;144(10):753-61 - PubMed
  4. Dentomaxillofac Radiol. 2006 Jul;35(4):236-43 - PubMed
  5. Skeletal Radiol. 2007 Nov;36(11):1017-27 - PubMed
  6. AJR Am J Roentgenol. 2007 Jun;188(6):1622-35 - PubMed
  7. J Clin Oncol. 2007 Sep 10;25(26):4104-9 - PubMed
  8. Eur J Radiol. 2008 Jan;65(1):47-58 - PubMed
  9. AJR Am J Roentgenol. 2008 Apr;190(4):949-55 - PubMed
  10. BMJ. 2009 Feb 25;338:b815 - PubMed
  11. J Magn Reson Imaging. 2010 Jul;32(1):2-16 - PubMed
  12. Acta Radiol. 2011 Jun 1;52(5):557-61 - PubMed
  13. Eur Radiol. 2011 Dec;21(12):2604-17 - PubMed
  14. Radiographics. 2011 Nov-Dec;31(7):2059-91 - PubMed
  15. Radiology. 2011 Dec;261(3):700-18 - PubMed
  16. Cancer Imaging. 2011 Oct 03;11 Spec No A:S129-45 - PubMed
  17. AJR Am J Roentgenol. 2012 Aug;199(2):252-62 - PubMed
  18. J Magn Reson Imaging. 2014 May;39(5):1049-78 - PubMed
  19. Radiographics. 2014 Mar-Apr;34(2):330-42 - PubMed
  20. PLoS One. 2014 Apr 07;9(4):e91779 - PubMed
  21. Eur J Cancer. 2014 Oct;50(15):2519-31 - PubMed
  22. Ann Oncol. 2015 Jun;26(6):1048-57 - PubMed
  23. World J Radiol. 2015 Aug 28;7(8):202-11 - PubMed
  24. Insights Imaging. 2016 Feb;7(1):131-44 - PubMed
  25. Eur J Radiol Open. 2015 Dec 11;3:16-21 - PubMed
  26. Radiology. 2016 May;279(2):345-65 - PubMed
  27. Eur Urol. 2017 Jan;71(1):81-92 - PubMed
  28. Ann Oncol. 2017 Dec 1;28(12):3111 - PubMed
  29. Eur J Cancer. 2017 May;77:109-116 - PubMed
  30. Ann Oncol. 2017 Jul 1;28(suppl_4):iv52-iv61 - PubMed

Publication Types